Blog
LATEST ALERTS
-
Luxembourg Bill to legalise cannabis plant cultivation expected in June… - Delaware - United States Recreational cannabis bill fails to pass…
- United States Califf says congressional action needed for CBD…
- United States First federal appeals court rules on the legality of delta-8 products…
- Germany Government to set cannabis possession limit…
- Colombia New forum to be held to provide information on cannabis legislation…
- Guyana Hemp bill presented to National Assembly…
- Thailand Cannabis growth without approval from June…
- New Zealand Three new medical cannabis products are approved…
- Europe EU to update hazardous substances list…
- Europe Stakeholder event on tobacco taxation in the EU held today…
- New York - United States Senate passes bill relating to business development and promotion of hemp…
How likely is it that the US will see further delta-8 THC enforcement?
Written by Freddie Dawson || 12th May 2022 || Blog , Regulatory briefing |
The US Food and Drug Administration (FDA) recently sent its first round of letters concerning delta-8 THC to five companies. How likely is it that the US will see further delta-8 THC enforcement? ...
UK FSA updates novel food list – but what difference will it make to the market?
Written by Freddie Dawson || 5th May 2022 || Blog , Business briefing |
The recent update to the UK Food Standards Agency (FSA)’s list of CBD products linked to validated novel food applications has created further issues and questions in the industry – such as, what will actually change? ...
The common sense of CBD science, and why it doesn’t always come to the fore
Written by Barnaby Page || 21st April 2022 || Blog , Business briefing |
Is the current system of peer-reviewed journal publication the best way to get the best science on CBD and cannabis? There could be another way ...
Polish court decision on hemp as novel food could have big ramifications
Written by Freddie Dawson || 14th April 2022 || Blog , Regulatory briefing |
A Polish appeals court has put forward a decision that may be out of kilter with many other interpretations of the status of hemp as a novel food ...
Will Canadian government’s proposal put renewed fizz in cannabinoid drinks?
Written by Lorraine Mullaney || 6th April 2022 || Blog , Business briefing |
Is the Canadian government’s proposal to increase the number of cannabis-infused drinks that can be legally purchased at one time good news for firms that have invested in cannabinoid-infused beverages? ...
Are there lessons for cannabinoids from the new synthetic-nicotine regulation?
Written by Freddie Dawson || 24th March 2022 || Blog , Regulatory briefing |
Could the cannabinoid industry learn anything from the recent move to close the loophole that had kept synthetic nicotine out of US Food and Drug Administration oversight? ...
Another sign of mainstream acceptance as Amazon gets on board with CBD in US
Written by Freddie Dawson || 21st March 2022 || Blog , Business briefing |
Interest from major players in traditional retail channels continues to grow ...
Is investing in cannabis in 2022 a smart bet or a ‘dead-money scenario’?
Written by Lorraine Mullaney || 9th March 2022 || Blog , Business briefing |
Last month CBD-Intel reported that the Dermapharm Holding bought Canopy Growth’s Cannabinoid Compound Company (C3) for €80m, a huge loss for Canopy, and one of the biggest cannabis acquisitions in Europe at the time. But what makes an acquisition a...
NORML releases delta-8 THC info that’s both misleading and potentially divisive
Written by Freddie Dawson || 3rd March 2022 || Blog , Regulatory briefing |
One of the most prestigious cannabis legalisation lobbying groups has come out with a disappointing – but not surprising – strong line against hemp-derived delta-8 THC products ...
The changing face of endorsements as they get more mainstream – and whiter
Written by CBD-Intel || 17th February 2022 || Blog , Business briefing |
What was once the purview of more “controversial” or “alternative” names has now become the territory of mainstream celebrities designed to appeal to a wider – and whiter – audience ...
Only in California: the fresh vape that’s cannabis and nothing but the cannabis
Written by Aidan Semmens || 9th February 2022 || Blog , Business briefing |
The latest offering from the company that first devised the Juul e-cigarette looks sure to be a new Californian craze – a new vaping pod “made solely from pure cannabis” ...
Will UK FSA at last publish an updated list of validated novel food applications?
Written by Freddie Dawson || 2nd February 2022 || Blog , Regulatory briefing |
Don't hold your breath, but rumours are swirling that the UK Food Standards Agency (FSA) will soon publish an updated, completed list of CBD novel food applications that have been fully validated ...
Despite industry investment, the future remains cloudy for cannabinoid drinks
Written by Lorraine Mullaney || 20th January 2022 || Blog , Business briefing |
Covid has significantly increased consumer interest in health and wellness, with food and drink formulations that create innovative solutions for “mental and emotional wellbeing” becoming a 2021 trend ...
How US Democrats’ cannabis reform plans ran aground despite promises
Written by Lorraine Mullaney || 12th January 2022 || Blog , Regulatory briefing |
After early promise, no cannabis-focused legislation has yet made it onto president Joe Biden’s desk for signing. So why is that? ...
Colombian insurance policy shows real intent to lead on cannabinoids
Written by Freddie Dawson || 6th January 2022 || Blog , Business briefing |
Colombia has joined a select few countries now demanding mandatory coverage of medical cannabis by health insurance providers ...
Legal eagle Kight explains how the USPS could have modified PACT Act regulation
Written by CBD-Intel || 22nd December 2021 || Blog , Regulatory briefing |
Does the United States Postal Service (USPS) really have the authority to permit the shipping of CBD vaping products under the PACT Act? ...
Florida bill will not distinguish delta-8 THC from other hemp-derived products
Written by Freddie Dawson || 16th December 2021 || Blog , Regulatory briefing |
There are incorrect reports that a proposed bill in Florida would regulate delta-8 THC products in the state. In fact the bill will place limitations on the sale of all hemp-derived products ...
What do Luxembourg and Malta’s legal cannabis plans mean in practice?
Written by Freddie Dawson || 9th December 2021 || Blog , Business briefing |
Will proposed plans to legalise recreational cannabis in Luxembourg and Malta change much in terms of EU business? ...
New German coalition plans to legalise cannabis – but when will sales begin?
Written by Freddie Dawson || 25th November 2021 || Blog , Regulatory briefing |
The newly elected German governing coalition has followed through on pre-election promises and included a plan for cannabis legalisation in its coalition agreement – but many questions remain to be answered ...
Why are specialist vape retailers around the world turning away from CBD online?
Written by Freddie Dawson || 17th November 2021 || Blog , Business briefing |
More and more vape specialists appear to be moving away from selling CBD vaping products, according to online market data produced by CBD-Intel ...
eBay prepares to take on Amazon with the launch of UK trial of CBD sales
Written by Freddie Dawson || 10th November 2021 || Blog , Business briefing |
eBay is set to launch a CBD trial, sources tell CBD-Intel. The internet marketplace that built its name as an auction site is said to be anticipating a November start for its UK...The suspense continues, still with no end in sight to the UK’s novel food saga
Written by Freddie Dawson || 3rd November 2021 || Blog , Regulatory briefing |
October has ended and November begun with still no further update from the UK Food Standards Agency (FSA) on the ongoing novel food application...
US states fall over themselves backwards to sow further confusion over delta-8
Written by Anthony Traurig || 21st October 2021 || Blog , Regulatory briefing |
A few US states may have over-corrected course in their rushing to modify regulations to cover hemp-derived delta-8 THC ...
Charlotte’s Web new dietary ingredient application did include ValidCare data
Written by Freddie Dawson || 14th October 2021 || Blog , Business briefing |
It turns out the Charlotte’s Web application to the US FDA for the registration of a full spectrum hemp extract as a new dietary ingredient (NDI) DID include data from the ValidCare industry study ...
Could CBD companies face scrutiny from another US regulatory agency?
Written by Freddie Dawson || 6th October 2021 || Blog , Regulatory briefing |
Does the CBD industry now face increased scrutiny from the US Securities and Exchange Commission (SEC)? ...
What does the recent USPTO trademark decision mean for the industry?
Written by Freddie Dawson || 22nd September 2021 || Blog , Regulatory briefing |
The USPTO Appeals Board verdict upholding the USPTO's decision to not grant Joy Tea a trademark covering CBD beverages should come as no surprise ...
FDA and CDC warnings won’t signal the end of the delta-8 THC market in the US
Written by Freddie Dawson || 16th September 2021 || Blog , Regulatory briefing |
The US Food and Drug Administration (FDA) and Centers for Disease Control (CDC) have issued warnings about the rise of reported incidents in the US regarding the use of delta-8 THC ...
Beverage brands still searching for the right solution to their drink problem
Written by CBD-Intel || 9th September 2021 || Blog , Business briefing |
CBD beverages continue to be a popular niche sub-category for producers, with brands still experimenting and bringing out new variations. Some significant regulatory concerns remain for the mid/long-term. Neither the US, UK or EU has explicitly permitted CBD...
Could Colombia’s reversal on allowing medical cannabis flower exports impact the global market?
Written by CBD-Intel || 1st September 2021 || Blog , Regulatory briefing |
There are always people claiming that new changes mean some such country will be "The next big X in cannabis or hemp". Recent examples include North Macedonia, Thailand, Brazil, Paraguay, Lesotho, Malawi, and of course, Colombia ...
What conclusions can be drawn from the FDA rejection of full hemp extracts as supplements?
Written by CBD-Intel || 18th August 2021 || Blog , Regulatory briefing |
The FDA recently rejected applications from both Charlotte's Web and Irwin Naturals to use a hemp extract as a dietary supplement ...
What lies behind the CBD industry’s continued interest in the field of nicotine replacement?
Written by CBD-Intel || 11th August 2021 || Blog , Business briefing |
A new study has shown some limited effectiveness for the use of CBD in combatting nicotine withdrawal symptoms ...
Could e-cig ‘shake and vape’ be a model for sales of ingestible CBD products?
Written by CBD-Intel || 5th August 2021 || Blog , Regulatory briefing |
There remains no certainty over the future regulation of ingestible CBD products in many jurisdictions ...
What can be concluded from the appointment of Lina Khan as new chair of the Federal Trade Commission (FTC)?
Written by CBD-Intel || 22nd July 2021 || Blog , Regulatory briefing |
Lina Khan's appointment to chair the US Federal Trade Commission (FTC) – confirmed last month – was a bit of a surprise ...
EU novel food assessment: No easy end in sight
Written by CBD-Intel || 16th July 2021 || Blog , Business briefing |
CBD growth in the UK could be boosted by a report from a new taskforce on post-Brexit regulatory change. But how likely is it that the recommendations will be implemented? ...
Why the UK government might not follow task force advice on homegrown hemp
Written by CBD-Intel || 8th July 2021 || Blog |
CBD growth in the UK could be boosted by a report from a new taskforce on post-Brexit regulatory change. But how likely is it that the recommendations will be implemented? ...
UK taskforce urges reform – but will it happen, and will it boost the market?
Written by Freddie Dawson || 28th June 2021 || Blog |
CBD growth in the UK could be boosted by a report from a new taskforce on post-Brexit regulatory change. But how likely is it that the recommendations will be implemented? ...
Why is crowd-funding an increasingly popular option for CBD companies to raise investment?
Written by JuditBach || 21st June 2021 || Blog |
Nordic Oil’s announcement of a crowd-funding launch on Seedrs is the latest in a growing queue of crowd-funding announcements. There are several reasons why even large CBD brands are increasingly turning towards crowd-funding as a method for raising...
What changes can be expected in the near future for the regulation of CBD in France?
Written by JuditBach || 11th June 2021 || Blog |
A draft proposal clarifying CBD regulations in France could lead to further enforcement on the sales of CBD products – heavily impacting the current make-up of the French market in the process. The draft arrêté, not publicly available...
New UK cannabis industry body brings together a wide range of expertise
Written by CBD-Intel || 3rd June 2021 || Blog |
A new UK cannabis industry association claims to be the first to bring together members from every aspect of the industry – with a range of more than 100 members already ...
Is delta-8 THC a legal product in the US?
Written by CBD-Intel || 20th May 2021 || Blog |
CBD-Intel’s opinion from a reading of laws at the federal level is that – currently – delta-8 THC should be considered legal if derived from a legal hemp plant. This is because the federal definition of hemp encompasses...
What can we learn from the distribution of brands by main product category and retailer type in the UK?
Written by CBD-Intel || 14th May 2021 || Blog |
CBD-Intel’s new UK online report highlights a number of interesting market developments. Among them is the information that brand distribution provides. From a dominance perspective, more brands are now being listed for cosmetic than vape products. This shows...
Could CBD/hemp vaping equipment be exempt from the incoming rule prohibiting the mailing of e-cigarette and vaporiser-related products through the US Postal Service (USPS)?
Written by CBD-Intel || 7th May 2021 || Blog |
Recent consultation guidance does suggest that the USPS is considering broadly exempting hemp and CBD services from the incoming rule. The guidance states: “For hemp-based products containing CBD with a THC concentration not exceeding 0.3 percent, mailers must...
What is the state of science behind minor cannabinoids really like?
Written by CBD-Intel || 29th April 2021 || Blog |
Minor cannabinoids are gaining increasing interest – pushed by both slowly growing consumer awareness and companies looking to develop further revenue streams from under-utilised products. A number of claims have been made about the properties of various minor...
How fast is the UK Food Standards Agency (FSA) novel food application validation process moving?
Written by CBD-Intel || 22nd April 2021 || Blog |
It does not look like good news. The only two companies (controlling three brands that contain 23 individually listed products) included in the initial list of validated applications both say they submitted their applications to the FSA in...
Is delta-8 THC really the next big thing?
Written by CBD-Intel || 14th April 2021 || Blog |
From a consumer/market perspective, it certainly looks like delta-8 THC is the most promising minor cannabinoid. It has quickly overtaken others such as CBG and CBN in terms of general awareness and – anecdotally – in terms of interest from companies...
Should CBD companies operating in the US be worried about the latest round of FDA enforcement?
Written by CBD-Intel || 8th April 2021 || Blog |
Four new letters sent by the US Food and Drug Administration (FDA) in the month of April mark a bit of a change in approach. Two of them were fairly standard warnings about health claim marketing potentially in...
Now that the deadline for applications has passed, when should enforcement action from the UK Food Standards Agency (FSA) be expected?
Written by CBD-Intel || 1st April 2021 || Blog |
The FSA told CBD-Intel during a recent conference that – unsurprisingly – no actions would be taken until after the list of validated/administratively checked pending validation applications had been published. Thus far no date for the publication of the...
Was the UK FSA decision to make changes to the novel food application timeline really that unexpected?
Written by CBD-Intel || 25th March 2021 || Blog |
The UK Food Standards Agency (FSA) has ruffled a few feathers by changing its criteria for allowing products to stay on the market. Instead of requiring a validated novel food submission, it now only requires a submission that...